Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact
  • Home
  • ›
  • Malignant Mesothelioma
  • ›
  • Treatment
  • ›
  • Medications
  • ›
  • Cytoxan (cyclophosphamide)
Page Updated: February 06, 2022

Cytoxan (cyclophosphamide)

Kyle J. Becker Page Medically Reviewed and Edited by Kyle J. Becker, PharmD, MBA, BCOP

FREE Mesothelioma Packet

Fact Checked

This page has been fact checked by a Doctor of Pharmacy who specializes in Oncology. Sources of information are listed at the bottom of the article.

FREE Mesothelioma Packet

We make every attempt to keep our information accurate and up-to-date.

Please Contact Us with any questions or comments.

Cytoxan (cyclophosphamide) is a chemotherapy drug that has been used to treat cancer since its approval by the U.S. Food and Drug Administration (FDA) in 1959.[1] Although not approved for any type of mesothelioma, doctors may prescribe Cytoxan as part of treatment. Research and clinical trials show that Cytoxan can help control mesothelioma when combined with other chemotherapeutic agents in some patients.

FREE Mesothelioma Packet

What is Cyclophosphamide?

Cyclophosphamide is manufactured by Baxter Healthcare Corporation and is distributed under the name Cytoxan.[1] Other companies, including Roxane Laboratories, make and distribute it as the generic drug cyclophosphamide. It comes in both tablet and intravenous forms.

The FDA first approved cyclophosphamide in 1959, and it is currently approved for treating several malignancies. These include several lymphoma types, multiple myeloma, neuroblastoma, ovarian adenocarcinoma, breast carcinoma, retinoblastoma, and leukemia.

Cyclophosphamide is also approved for use in pediatric patients with a condition called nephrotic syndrome, which often doesn’t respond well to other treatments.[1]

How Cyclophosphamide Works

Cyclophosphamide is an alkylating agent. This means it is a drug that interferes with cell DNA, preventing cells from growing and dividing. It is also an immunosuppressant, meaning it impairs the function of the immune system.

The drug’s effects on the immune system make it useful for treating nephrotic syndrome and some autoimmune disorders, though it is not currently approved for the latter.

As a chemotherapeutic agent, it is the alkylating effect that makes it effective. Unlike other chemotherapy drugs, Cytoxan does not have to be given intravenously; instead, it can be taken by mouth in capsule form.[1]

Common Side Effects

Cyclophosphamide causes side effects similar to those caused by other chemotherapy drugs. These side effects include:[2]

  • Hair loss
  • Fever
  • Nausea
  • Diarrhea
  • Vomiting
  • Loss of appetite
  • Weight loss
  • Mouth and tongue sores

Cytoxan also reduces the number of white blood cells in the body. White blood cells are a key component of the immune system; therefore, patients receiving this treatment can be more prone to infections and closely monitored.

Infrequently, the drug may cause severe immunosuppression, leading to bone marrow failure and possibly life-threatening infections.[1]

Other Side Effects

There are more serious side effects of Cytoxan, though they are less common. These include toxicity for certain organs in the body, like the bladder and kidneys. Toxicity can cause bleeding and bladder infections.

In some patients, toxicity in the heart has also been reported, leading to heart infections, congestive heart failure, and arrhythmias. Pulmonary infections and respiratory failure are also possible.[1]

Cyclophosphamide can cause serious birth defects, so it is contraindicated for pregnant women or may become pregnant.[1]

The Risk of Developing Other Cancers

Long-term treatment with cyclophosphamide significantly increases the risk of developing secondary cancers. Some secondary cancers that have been reported include leukemia, lymphoma, sarcoma, thyroid cancer, myelodysplasia, and urinary tract cancer.[2]

Preventing and treating bladder infections can help prevent secondary bladder cancer. Developing a secondary cancer is less of a concern for mesothelioma patients because the benefit balances the risk, and secondary cancers can take many years to develop.

Cyclophosphamide Chemotherapy Combinations for Pleural Mesothelioma

While Cytoxan is not FDA-approved for treating mesothelioma, it has been used in some clinical trials to determine its safety and effectiveness. Some results are promising, while others show poor results; however, research is ongoing.

One study involved forty-seven patients with pleural mesothelioma given radiation therapy. Some patients were then given chemotherapy with a combination of cyclophosphamide and doxorubicin in addition to the radiation therapy.

The results showed those patients receiving the combination of chemotherapy drugs saw reductions in tumor size. These patients had an average survival time of thirteen months, while those who did not receive the chemotherapy drugs averaged only six months.[3]

A study from 2017 combined cyclophosphamide with immunotherapy treatments that target an overexpressed tumor gene typical in mesothelioma patients. Although it was a small study, the researchers saw a good response in half of the patients.[4]

Clinical Trials

Mixed results notwithstanding, there are currently several clinical trials ongoing, near completion, or recruiting participants, using cyclophosphamide to treat pleural mesothelioma. One trial is using the drug in combination with surgery and other drugs to reduce tumor size.

Another trial used it with an experimental immunotoxin called SS1P.[5] Yet another trial combined cyclophosphamide with vaccine therapies.[6]

While some studies have concluded, others need eligible mesothelioma patients. One study in the recruiting phase is using cyclophosphamide with cord-blood natural killers cells and another chemotherapy drug.[7]

Eligible patients may also join an ongoing clinical trial using cyclophosphamide along with an immunotherapy called CAR T-cell therapy. It involves altering a patient’s T-cells and so that they recognize and kill cancer cells.[8]

Cytoxan is an old chemotherapy drug but is finding new life in treating conditions like mesothelioma. Proven for decades to help treat certain cancers, cyclophosphamide is being tested with the most difficult types of cancer, including mesothelioma. While there are serious concerns, risks, and side effects, this drug also has potential, especially when combined with other treatments.

Get Your FREE Mesothelioma Packet

Page Medically Reviewed and Edited by Kyle J. Becker, PharmD, MBA, BCOP

Kyle J. Becker

Kyle J. Becker, PharmD is certified by the Board of Pharmacy Specialties in Oncology Pharmacy. Dr. Becker earned his pharmacy degree from Shenandoah University and he currently serves as an oncology pharmacist at Parkview Cancer Institute.

Connect with Oncology Pharmacist Kyle J. Becker
References
  1. U.S. Food and Drug Administration. (2013, May). Cyclophosphamide.
    Retrieved from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012141s090,012142s112lbl.pdf
  2. MedlinePlus. (2018, August, 15). Cyclophosphamide.
    Retrieved from: https://medlineplus.gov/druginfo/meds/a682080.html
  3. LInden, C-J., Mercke, C., Albrectsson, U., Johansson, L., and Ewers, S-B. (1996). Effect of Hemithorax Irradiation Alone or Combined with Doxorubicin and Cyclophosphamide in 47 Pleural Mesotheliomas: A Nonrandomized Phase II Study. Eur. Respir. J. 9, 2565-72.
    Retrieved from: https://erj.ersjournals.com/content/erj/9/12/2565.full.pdf
  4. Lee, S., Chapuis, A., Schmitt, T., Goulart, B., Mcafee, M., Perdicchio, M., Yeung, C., Nguyen, H., Wagener, F., Hunter, D., Bui, K., Delismon, J., Duerkopp, N., and Greenberg, P. (2017, January 1). P3.03-063 Phase 1/2 Trial of WT1 TCR-Transduced Central Memory and Naïve CD8+T Cells for Patients with Mesothelioma and Non-Small Cell Lung Cancer. J. Thorac. Oncol. 12(1), S1384-85.
    Retrieved from: https://www.jto.org/article/S1556-0864(16)33203-8/fulltext
  5. National Cancer Institute (NCI). (2019, June 6). SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma.
    Retrieved from: https://www.clinicaltrials.gov/ct2/show/NCT01362790
  6. National Cancer Institute. (2020, March 3). Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas.
    Retrieved from: https://www.clinicaltrials.gov/ct2/show/NCT01143545
  7. M.D. Anderson Cancer Center (2021, April 29). Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors.
    Retrieved from: https://www.clinicaltrials.gov/ct2/show/NCT03420963
  8. Memorial Sloan Kettering Cancer Center. (2021, July 20). Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma.
    Retrieved from: https://clinicaltrials.gov/ct2/show/NCT04577326
View All References

Site Navigation

Home
Malignant Mesothelioma
How to Survive Mesothelioma
100 Questions & Answers about Mesothelioma (Free Book)
Surviving Mesothelioma - Beating the Odds (Free Book)
FREE Mesothelioma Packet
Symptoms
Shortness of Breath
Cough
Night Sweats and Fever
Weight Loss
Pain
Difficulty Swallowing
Fatigue and Muscle Weakness
Gastrointestinal Complications
Diagnosis
Pathology
Staging
Stage 1
Stage 2
Stage 3
Stage 4
Metastasis and Progression
Brain Metastasis
Biopsy
miRview Test
Imaging
Fine Needle Aspiration Biopsy
Biomarkers and Blood Tests
Calretinin
Prognosis
Remission
Recurrence
Death Rate
Life Expectancy
Search for a Mesothelioma Cure
Types
Pleural
Peritoneal
Epithelioid
Sarcomatoid
Biphasic
Pericardial
Testicular
Cell Types
Rare Subtypes of Epithelial Mesothelioma
Deciduoid
Desmoplastic
Heterologous
Lymphohistiocytoid
Well-Differentiated Papillary
Tubulopapillary
Small Cell
Benign
Adenomatoid
Cystic
Unresectable
Localized
Idiopathic
Omental
Causes
Risk Factors
Latest Research
Genetic Components
Incidence
Latency Period
Mesothelioma Tumor
Health Insurance Coverage
Related Conditions
Immunodeficiency Disorders
Cholangiocarcinoma
Atelectasis
Pleural Plaques
Pleural Thickening
Pleural Effusion
Peritoneal Effusion (Ascites)
Mesothelial Hyperplasia and Proliferation
Pleuritis and Pleurisy
COPD
Anemia
Breast Cancer
Prevention
Complications
Misdiagnosis
Mesothelioma Commercial
Talcum Baby Powder
Lawyer
Lawsuits
Class Action Lawsuits
Settlements
Simian Virus 40
Differences From Other Cancers
Lung Cancer
Women
Children and Young Adults
Unknown Asbestos Exposure
Mesothelioma Without Asbestos
Cause of Death
Facts 
History
Awareness
Government and Research
National Mesothelioma Virtual Bank
Support
What to Expect
Living with Mesothelioma
Help a Loved One
Wrong and Right Things to Say
Caregivers
Financial Tips
Faith
Nutrition and Lifestyle
Intimacy
Mesothelioma and Fertility in Men
Fertility in Women with Mesothelioma
Emotional Health
COVID-19
Assisted Living
Hospice Care
Dying from Mesothelioma
Mourning
Coping Guide for Children
End-of-Life Decisions
Mesothelioma Awareness Day
Compensation for Victims
Lawyer
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington D.C.
Washington
West Virginia
Wisconsin
Wyoming
Lawsuit
Settlements
Statute of Limitations
Treatment
Surgery
Side Effects
Pneumonectomy
Extrapleural Pneumonectomy
Lobectomy
Pleurectomy / Decortication
Post Op Care
Pleurectomy / Decortication vs. Extrapleural Pneumonectomy
Peritonectomy/Cytoreductive Surgery
Thoracotomy
Thoracoscopy
Pericardiectomy
Wedge Resection
Pleurodesis
Pericardiocentesis
Prosthetics
Paracentesis
Thoracentesis
Chemotherapy
Side Effects
Heated Intraperitoneal
Radiation Therapy
Side Effects
Intensity-Modulated
Brachytherapy
Proton Therapy
Image-Guided
External Beam
Three-Dimensional
Multimodal Therapy
New Treatments
SMART Protocol
Gene Therapy
Suicide Gene Therapy
Tumor-Based p53 Therapy
Cryotherapy for Mesothelioma
Tumor Treating Fields
MicroRNA
Palliative Treatment
Osteopathic
Doctors
Treatment Centers
Treatment & Doctors Near You
Mesothelioma Experts
Medications
Alimta (pemetrexed)
Adriamycin (doxorubicin)
Avastin (bevacizumab)
Cytoxan (cyclophosphamide)
Gemzar (gemcitabine)
Keytruda (Pembrolizumab)
Mitomycin
Navelbine (vinorelbine)
Opdivo (nivolumab) and Yervoy (ipilimumab)
Paraplatin (carboplatin)
Platinol (cisplatin)
Rheumatrex (methotrexate)
Sutent (sunitinib)
Taxol (paclitaxel)
Medical Marijuana
Care Providers
Clinical Trials
Anetumab Ravtansine
Atezolizumab
Chimeric Antigen Receptor (CAR) T-Cell
Durvalumab
Immunotoxin
Interferon Alfa-2b
Onconase (Ranpirnase)
VISTA Protein
Costs
Immunotherapy
Nanotechnology
Hyperbaric Oxygen Therapy
Home Medical Equipment
HMGB1 Secretion
Photodynamic Therapy
Targeted Therapies
Apoptosis
Stem Cells
Lung Transplantation
Body-Based Therapies
Alternative Therapies
Paul Kraus’s Method
Doctors and Treatment in Canada
Asbestos Trusts
Veterans
VA Claims for Mesothelioma
Vietnam Veterans
Military Branches and Asbestos
Navy Veterans
Navy Ships
Aircraft Carriers
Battleships
Destroyers
Asbestos on Navy Cruisers
Submarines
Amphibious Ships
Minesweepers
Auxiliary Ships
Marine Corps Veterans
Army Veterans
Air Force Veterans
U.S. Coast Guard
Asbestos
Occupational Exposure
Construction Workers
Shipyard Workers
Ship Repair
Steel Mill Workers
Industrial Workers
Boiler Workers
Power Plant Workers
Firefighters
Automotive Workers
Roofers
Oil Refineries
Mining
Transportation Industry
Machine Operators
Farmers and Agricultural Workers
Migrant Workers
Electrical Wiring
Labor Unions
Prisons
Chimneys, Furnaces, and Wood Stoves
Fiberglass Connection to Mesothelioma
Home Remodeling
School Buildings, Teachers
For Tech Students
Cancer
Lung Cancer
Pleural Based Cancers
Ovarian Cancer
Ovarian Cancer Lawsuits
Companies That Used Asbestos
Awareness and Education
Types of Asbestos & Mesothelioma Risk
Asbestosis
Interstitial Lung Disease
Smoking
Asbestos Ingestion
Exposure in a Natural Disaster
Ban Asbestos
Libby, Montana
Recycling Asbestos
Asbestos Detection
Legal Information by State
Canada
Mexico
United Kingdom
Australia
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net